Table 2.
Patient ID | Patient gender | Patient age | Tumor histology* | Tumor size | Fuhrman grade | pTNM*** |
---|---|---|---|---|---|---|
SS001 | Male | 58 | RCC, clear cell | 24.0 cm | 3 | pT3b, pN1, pMX |
SS002 | Male | 68 | RCC, clear cell | 5.4 cm | 4 | pT1b, pNX, pMX |
SS003 | Male | 64 | RCC, clear cell | 3.8 cm | 2 | pT3, pNX, pMX |
SS004 | Male | 74 | RCC, clear cell | 4.5 cm | 4 | pT3a, pNX, pMX |
SS005 | Male | 73 | RCC, clear cell | 5.0 cm | 4 | pT1, PNX, pM1 |
SS006 | Male | 56 | RCC, clear cell | 8.5 cm | 3 | pT3a, pNX, pMX |
SS008 | Female | 63 | RCC, clear cell | 5.0 cm | 4 | pT3a, pNX, pMX |
SS009 | Female | 75 | RCC, clear cell | 2.4 cm | 2 | pT3b, pNX, pMX |
SS010 | Female | 69 | RCC, clear cell | 6.5 cm | 4 | pT1b, pNX, pMX |
SS012 | Female | 64 | RCC, clear cell | 13.4 cm, 2.0 cm** | 3 | pT3, pNX, pM1 |
SS013 | Male | 61 | RCC, clear cell | 13.0 cm | 3 | pT3a, pN0, pM1 |
*RCC: renal cell carcinoma.
**Two measurements for the foci in a multicentric tumor.
*** pTNM: p: pathologic stage; T: primary tumor size; N: regional lymph node status; M: distant metastatic sites.